Recent human phase II studies showed that sustained Mtb infection can be prevented by BCG revaccination of Mtb uninfected individuals (as measured by interferon gamma release assay conversion), and that incidence of new TB cases can be reduced amongst persons with LTBI by the M72 TB subunit vaccine (4, 5). Here, IFNG is linked to tuberculosis.